Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jean George currently holds 14,150 shares of CATABASIS PHARMACEUTICALS INC (CATB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jean George has been a net seller of CATB stock. They have purchased $6.1M and sold $119.4M worth of shares.
Jean George's most recent insider trade was on Feb 14, 2024, when they sold 14,150 shares at $0.00 per share.
Jean George serves as Executive at CATABASIS PHARMACEUTICALS INC (CATB). They have executed 68 insider transactions totaling $125.5M over their tenure at the company.
Jean George holds the position of Executive at CATABASIS PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Jean George has shown a selling trading pattern, with $6.1M in total purchases and $119.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jean George was on Sep 30, 2016, when they sold $30.4M worth of XLRN shares. This transaction involved 857,145 shares at $35.50 per share.
Jean George currently owns 14,150 shares of CATABASIS PHARMACEUTICALS INC (CATB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jean George's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jean George has 68 Form 4 filings on record as an insider at CATABASIS PHARMACEUTICALS INC.
Set alerts for Jean George and 40,000+ other insiders.